Remember This? Alta Vista Cancels IPO. David Wetherell Takes a $2 Billion Beating.

We are going through some of our very old 'incubator files' back from when we ran the Incubator Stock Review, a spinoff...
Biotech Stock Review

True Nature (TNTY) Mitesco Set to Launch Mitesco PLC Incubator — Aligns With Matheson...

Hires Legal Powerhouse Matheson as Counsel and Advisor on its European Acquisitions Efforts. Established...
Internet Stock Review

What We’re Watching.

“Biotech, Beverages and Bears - Oh My!” — Daniel K. McMahon

True Nature (TNTY) Readies Launch of Mitesco: “The Medtech Incubator”

ATLANTA, GA, Nov. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- True Nature Holding, Inc. (OTCQB: TNTY, “the Company”) today announced that...

Medtech Incubator in Final Stages of Launch.

TrueNature (TNTY) Has Spent the Past Year Gearing Up. News of a Launch and First Incubation Effort Could be Around the Corner...

Emerald Organic (EMOR) to License Therapeutics Portfolio from Amarantus Bioscience Holdings (AMBS).

The portfolio includes treatments for Alzheimer’s disease, ADHD, Parkinson’s disease, vision loss and severe burns. Amarantus to receive Emerald Organics Preferred...
Dyadic, Biotech Stock Review

Dyadic (DYAI) $7.00 Called a ‘Gamechanger’ – Gets $14 Price Target.

Highly Respected Wall Street Analyst Jason Kolbert Issues $14.00 Price Target On Dyadic.
Dyadic

Investor Presentation Slides From Dyadic (DYA) $6.40.

Really, How Do We Do It? Live Short Term Chart
Mitesco

Healthcare Incubators and Wearable Devices.

Originally published August 22, 2019 The Global Wearable Devices Market is expected to exceed more than $51.50 billion by...

Dawson James Securities Announces 5th Annual Small Cap Growth Conference.

BOCA RATON, Fla., Sept. 25, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – Dawson James Securities, Inc. (“Dawson”), a full-service boutique investment banking firm focused...

Latest article

biogen, biotech stock review

Biotech’s Turning Up…

Biotech Sector Gains Near 10% in Past Month, After Biogen (BIIB) Reports Breaking News. We keep telling investors...
True Nature, Biotech Stock Review

True Nature | Mitesco (TNTY), Perking Up.

Is it too early to nick-name True Nature's Medtech incubator Mitesco the "Mighty Mitesco?" Of course it's too early - but it...
Dyadic, Biotech Stock Review

Dyadic (DYAI) Highlights.

"In just over a year and a half we have entered into over 15 proof of concept collaborations for both human and...